US FDA Staff Question Data on Dyax Corp. Drug Published: Feb 03, 2009 WASHINGTON, Feb 2 (Reuters) - U.S. drug reviewers are questioning data supplied by Dyax Corp to back an experimental drug to treat a rare swelling disorder, documents released on Monday said. Related links Reuters This will open in a new window Forbes This will open in a new window Email this Facebook Twitter LinkedIn Pinterest Reddit Back to news